Loading institutional data...
Loading institutional data...
Institutional accumulation: ownership increased +1.07% quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Top 34 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
4/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
Free-cash-flow coverage unavailable. Last year: $17M dividends + $0 buybacks = $17M returned on -$8M FCF.
1 consecutive years of dividend increases · 93%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -20%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $15M covers all $6M of scheduled principal — no refinancing pressure. Scheduled principal only (excludes interest & revolver draws). As of 2015-12-31 (10-K).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Interest last disclosed in FY2021 (no longer broken out).
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $27.6M 100.0% | $22.9M 100.0% | $11.1M 100.0% | $25.9M 100.0% | $18.3M 100.0% | $19.5M 100.0% | $20.6M 100.0% | $20.1M 100.0% | $114.4M 100.0% | $99.6M 100.0% |
| Cost of Revenue | $24.2M 87.6% | $17.4M 75.9% | $8.9M 80.0% | $23.1M 89.1% | $16.9M 92.4% | $18.6M 95.5% | $19.4M 94.3% | $87.1M 432.9% | $96.7M 84.5% | $77.5M 77.8% |
| Cost of Products | — | — | — | — | — | — | — | — | $80.5M 70.4% | $77.5M 77.8% |
| Gross Profit | $3.4M 12.4% | $5.5M 24.1% | $2.2M 20.0% | $2.8M 10.9% | $1.4M 7.6% | $881K 4.5% | $1.2M 5.7% | $1.9M 9.4% | $17.7M 15.5% | $22.1M 22.2% |
| Research & Development | $875K 3.2% | $1.1M 4.6% | $885K 8.0% | — | — | — | — | — | — | — |
| Selling, General & Admin | $9.1M 33.1% | $9.7M 42.4% | $8.4M 75.3% | $8.6M 33.4% | $5.3M 28.7% | $5.2M 26.5% | $12.9M 62.8% | $11.0M 54.7% | $21.2M 18.5% | $16.7M 16.8% |
| Total Operating Expenses | $10.0M 36.3% | $10.8M 47.0% | $9.3M 83.3% | $8.6M 33.4% | $5.3M 28.7% | $5.2M 26.5% | $12.9M 62.8% | $11.0M 54.7% | $21.1M 18.4% | $18.6M 18.7% |
| Operating Income | -$6.6M -23.9% | -$5.2M -22.9% | -$7.0M -63.3% | -$5.8M -22.5% | -$3.9M -21.1% | -$4.3M -22.0% | -$11.8M -57.1% | -$9.1M -45.3% | -$3.3M -2.9% | $3.6M 3.6% |
| Interest Expense | — | — | — | — | $4K 0.0% | $9K 0.0% | $396K 1.9% | $916K 4.6% | $2.5M 2.2% | $1.7M 1.7% |
| Interest & Investment Income | $739K 2.7% | $431K 1.9% | $232K 2.1% | — | — | — | — | — | — | — |
| Other Income (Expense), net | -$518K -1.9% | $50K 0.2% | $524K 4.7% | -$67K -0.3% | $1.3M 7.1% | $969K 5.0% | -$2.8M -13.7% | -$64K -0.3% | -$411K -0.4% | $554K 0.6% |
| Pretax Income | -$6.4M -23.1% | -$4.8M -20.8% | -$6.3M -56.5% | -$5.4M -20.9% | -$2.2M -11.9% | -$3.0M -15.3% | -$10.8M -52.3% | -$10.1M -50.2% | $857K 0.7% | $2.4M 2.4% |
| Income Tax Expense | $74K 0.3% | -$1.4M -6.2% | — | $7K 0.0% | -$16K -0.1% | $5K 0.0% | $1.3M 6.2% | -$796K -4.0% | $3.0M 2.7% | $925K 0.9% |
| Net Income | -$6.0M -21.7% | $31.9M 139.2% | -$1.9M -17.1% | -$5.4M -20.9% | -$2.2M -11.8% | -$3.0M -15.3% | -$1.0M -5.0% | -$5.7M -28.1% | -$9.2M -8.1% | -$1.1M -1.1% |
| Per Share | ||||||||||
| EPS (Basic) | $-0.54 | $2.97 | $-0.19 | $-0.56 | $-0.24 | $-0.34 | $-0.12 | $-0.65 | $-1.06 | $-0.12 |
| EPS (Diluted) | $-0.54 | $2.90 | $-0.20 | $-0.56 | $-0.24 | $-0.34 | $-0.12 | $-0.65 | $-1.06 | $-0.12 |
| Weighted Avg Shares (Basic) | 11.1M | 10.7M | 9.9M | 9.7M | 8.9M | 8.7M | 8.7M | 8.7M | 8.7M | 8.7M |
| Weighted Avg Shares (Diluted) | 11.2M | 11.0M | 10.1M | 9.7M | 8.9M | 8.7M | 8.7M | 8.7M | 8.7M | 8.7M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-09-17
No standout strengths flagged.
Where each multiple sits in its own 13-yr range · 58th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 13-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 432.9 | 94.3 | 95.5 | 92.4 | 89.1 | 80.0 | 75.9 | 87.6 |
| Gross Profit | 9.4 | 5.7 | 4.5 | 7.6 | 10.9 | 20.0 | 24.1 | 12.4 |
| R&D | — | — | — | — | — | 8.0 | 4.6 | 3.2 |
| SG&A | 54.7 | 62.8 | 26.5 | 28.7 | 33.4 | 75.3 | 42.4 | 33.1 |
| Operating Income | -45.3 | -57.1 | -22.0 | -21.1 | -22.5 | -63.3 | -22.9 | -23.9 |
| Income Tax | -4.0 | 6.2 | 0.0 | -0.1 | 0.0 | — | -6.2 | 0.3 |
| Net Income | -28.1 | -5.0 | -15.3 | -11.8 | -20.9 | -17.1 | 139.2 | -21.7 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on PPSI: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Ranked against 651 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LTM | $28.75T | — | — | — | — | — | — | — | — | — | 160 |
| CAT | $364.2B | 41.6× | 29.1× | 5.4× | 4.3% | 33.8% | 13.1% | 41.7% | 15.4% | 2.7× | 3,616 |
| GE | $328.2B | 38.4× | — | 7.2× | 18.5% | — | 19.0% | 46.6% | 22.2% | — | 3,077 |
| RTX | $264.2B | 39.7× | 18.8× | 3.0× | 9.7% | — | 7.6% | 10.3% | 10.3% | 0.0× | 3,277 |
| BA | $204.4B | 81.4× | 41.0× | 2.3× | 34.5% | 4.8% | 2.5% | 41.0% | 3.3% | 10.0× | 2,435 |
| DE | $181.0B | 36.2× | — | 4.0× | -11.7% | — | 11.0% | 19.4% | 12.6% | — | 2,491 |
| ABBNY | $174.3B | 47.1× | 31.1× | 5.4× | 9.5% | 34.8% | 11.9% | 28.5% | 20.4% | 0.9× | 48 |
| UNP | $166.7B | 23.4× | 16.0× | 6.8× | 1.1% | — | 29.1% | 38.7% | 14.2% | 2.6× | 2,648 |
| ETN | $154.3B | 38.1× | — | 5.6× | 10.3% | 37.6% | 14.9% | 21.0% | 13.9% | — | 2,398 |
| HON | $131.9B | 28.2× | 16.2× | 3.5× | 7.8% | 36.9% | 12.6% | 34.0% | 9.8% | 3.6× | 2,694 |
| LMT | $123.0B | 25.0× | 16.1× | 1.6× | 5.6% | 10.2% | 6.7% | 74.6% | 17.7% | 2.5× | 2,807 |
| PH | $117.9B | 33.9× | 26.6× | 5.9× | -0.4% | 36.9% | 17.8% | 25.8% | 16.7% | 1.6× | 1,845 |
| ADP | $108.7B | 25.0× | — | 5.0× | 6.7% | 46.4% | 20.1% | 73.2% | 40.1% | — | 2,179 |
| GD | $97.3B | 23.3× | 17.1× | 1.9× | 10.1% | — | 8.0% | 16.4% | 12.5% | 1.3× | 2,123 |
| TT | $94.0B | 32.5× | 23.2× | 4.4× | 7.5% | — | 13.7% | 34.0% | 22.1% | 1.1× | 1,658 |
| PWR | $92.6B | 91.1× | 46.0× | 3.3× | 20.3% | 15.0% | 3.6% | 11.5% | 10.6% | 0.4× | 1,659 |
| VRT | $91.6B | 70.2× | 43.4× | 8.9× | 27.7% | 36.3% | 13.0% | 33.8% | 19.4% | 1.4× | 1,748 |
| JCI | $91.6B | 27.9× | — | 3.9× | 2.8% | 36.4% | 13.9% | 25.5% | 14.4% | — | 1,487 |
| HWM | $91.5B | 61.4× | 40.3× | 11.1× | 11.1% | — | 18.3% | 28.2% | 17.9% | 1.3× | 1,399 |
| CSX | $89.1B | 31.1× | 14.4× | 6.3× | -3.1% | — | 20.5% | 22.0% | 22.0% | — | 1,791 |
| MMM | $86.2B | 27.1× | 16.6× | 3.5× | 1.5% | 39.9% | 13.0% | 69.1% | 18.8% | 2.1× | 2,051 |
| WM | $86.2B | 31.9× | 12.1× | 3.4× | 14.2% | 40.4% | 10.7% | 27.1% | 25.3% | 0.1× | 2,262 |
| UPS | $83.9B | 15.1× | 9.4× | 0.9× | -2.6% | — | 6.3% | 34.3% | 13.8% | 2.2× | 2,025 |
| EMR | $82.1B | 36.1× | — | 4.6× | 3.0% | 52.8% | 12.7% | 11.3% | 6.9% | — | 2,112 |
| CTAS | $80.4B | 45.3× | 28.9× | 7.8× | 7.7% | 50.0% | 17.5% | 38.7% | 25.5% | 0.8× | 1,366 |
| PPSI | $36M | — | — | 1.3× | 20.8% | 12.4% | -21.7% | -20.5% | -20.5% | — | 34 |
Peers = companies sharing PPSI's sector (Industrials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.